NAD + in aging, metabolism, and neurodegeneration
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Nicotinamide adenine dinucleotide (NAD + ) is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a cosubstrate for other enzymes such as the sirtuins and poly(adenosine diphosphate–ribose) polymerases. Cellular NAD + concentrations change during aging, and modulation of NAD + usage or production can prolong both health span and life span. Here we review factors that regulate NAD + and discuss how supplementation with NAD + precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [68]
In the citing paper
“Nicotinamide phosphoribosyl transferase (NAMPT) catalyzes the rate limiting step in the NAD salvage pathway from nicotinamide (NAM) (Garten et al., 2015; Verdin, 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Verdin, 2015
In the citing paper
“Persistently activated PARP1, however, consumes large amounts of NAD+, an essential coenzyme of sirtuins (SIRTs) (69).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [69]
In the citing paper
“restoration of NAD levels with the NAD precursor vitamins nicotinamide riboside (NR), nicotinamide (NAM) and nicotinic acid (NA), in addition to the biosynthetic NAD precursor nicotinamide mononucleotide (NMN), appears to mitigate several age-associated diseases2-4.”
From Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages (2020) · cites this paper as [4]
In the citing paper
“The NAD+ salvage pathway starts from the recycling of nicotinamide (NAM) to nicotinamide mononucleotide (NMN) by intracellular nicotinamide phosphoribosyltransferase (iNAMPT), followed by the conversion of NMN into NAD+ via the NMNATs (Bogan and Brenner, 2008; Verdin, 2015).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Verdin, 2015
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
Braidy, N., Guillemin, G. J., Mansour, H., Chan-Ling, T., Poljak, A., & Grant, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019194 · Cited by 594
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Cited by
Items 501–600 of 1,000
NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling
Jiang, Y., Luo, Z., Gong, Y., Fu, Y., & Luo, Y. (2023) · Oncogene · doi:10.1038/s41388-023-02592-y · Cited by 30
Targeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis
Xiao, H., Xie, Y., Xi, K., Xie, J., Liu, M., Zhang, Y., Cheng, Z., Wang, W., Guo, B., & Wu, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0203 · Cited by 32
Ketone bodies in cell physiology and cancer
Giuliani, G., & Longo, V. D. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00441.2023 · Cited by 33
Morrison, E. J., Champagne, D., Dzieciątkowska, M., Nemkov, T. G., Zimring, J. C., Hansen, K. C., Guan, F., Huffman, D. M., Santambrogio, L., & D’Alessandro, A. (2019) · Nutrients · doi:10.3390/nu11061337 · Cited by 32
Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives
Ghanem, M. S., Caffa, I., Monacelli, F., & Nencioni, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042092 · Cited by 30
Nicotinamide N -Methyltransferase in Health and Cancer
Ramsden, D. B., Waring, R. H., Barlow, D. J., & Parsons, R. B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691739 · Cited by 29
Ewing sarcoma protein promotes dissociation of poly(ADP‐ribose) polymerase 1 from chromatin
Lee, S., Kim, N., Kim, S., Park, I. B., Kim, H.-J., Kim, S., Kim, B., Hwang, J. M., Baek, I., Gartner, A., et al. (2020) · EMBO Reports · doi:10.15252/embr.201948676 · Cited by 29
“Since the enzymatic activity of PARP1 is the major cause of NAD + depletion and consumes up to 80% of cellular NAD + to produce PAR chains in response to DNA damage (Verdin, 2015), we decided to determine whether the loss of EWS increased the level of PAR chains in mouse embryonic tissues.”
Nagineni, C. N., Naz, S., Choudhuri, R., Chandramouli, G. V. R., Krishna, M. C., Brender, J., Cook, J. A., & Mitchell, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094835 · Cited by 28
“PRPP has critical roles in purine and pyrimidine nucleotide, NAD, histidine and tryptophan biosynthesis [33,34,41].”
BackgroundMitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension
Dikalov, S., & Dikalova, A. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000771 · Cited by 28
“Indeed, animal and clinical studies showed potential benefits of nicotinamide riboside supplementation [21].”
BackgroundJi, H., Sapar, M. L., Sarkar, A., Wang, B., & Han, C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111818119 · Cited by 29
Cros, C. D., Margier, M., Cannelle, H., Charmetant, J., Hulo, N., Laganier, L., Grozio, A., & Canault, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.895028 · Cited by 31
“…primarily relies on the salvage pathway, in which nicotinamide (NAM) is recycled into β-nicotinamide mononucleotide (β-NMN), via nicotinamide phosphoribosyl transferase (NAMPT), and β-NMN is directly converted into NAD+ by nicotinamide mononucleotide adenylyl transferases (NMNATs) (Verdin, 2015).”
BackgroundHSF-1: Guardian of the Proteome Through Integration of Longevity Signals to the Proteostatic Network
Lázaro‐Peña, M. I., Ward, Z. C., Yang, S., Strohm, A. O., Merrill, A. K., Soto, C. A., & Samuelson, A. V. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.861686 · Cited by 30
“Sirtuins are (NAD+)-dependent deacetylases, which sense levels of NAD+, an important metabolite linked to longevity (Verdin 2015).”
BackgroundKynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
Cai, Z., Tian, S., Klein, T., Tu, L., Geenen, L. W., Koudstaal, T., van den Bosch, A. E., de Rijke, Y. B., Reiss, I. K. M., Boersma, E. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15039-3 · Cited by 29
Nicotinamide Administration Improves Remyelination after Stroke
Wang, C., Zhang, Y., Ding, J., Zhao, Z., Qian, C., Luan, Y., & Teng, G. (2017) · Neural Plasticity · doi:10.1155/2017/7019803 · Cited by 29
Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases
Dash, R., Jahan, I., Ali, M. C., Mitra, S., Munni, Y. A., Timalsina, B., Hannan, M. A., & Moon, I. S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105011 · Cited by 28
Kujundžić, R. N., Prpić, M., Đaković, N., Dabelić, N., Tomljanović, M., Mojzeš, A., Fröbe, A., & Gall‐Tros̆elj, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115681 · Cited by 30
“In this pathway, NAM phosphoribosyltransferase (NAMPT) converts NAM into the nicotinamide mononucleotide (NMN), which nicotinamide mononucleotide adenylyl-transferases 1–3 (NMNATs 1–3) convert into NAD+ [10].”
BackgroundCui, H., Ren, X., Dai, L., Chang, L., Liu, D., Zhai, Z., Kang, H., & Ma, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1145552 · Cited by 31
Advancements in NMN biotherapy and research updates in the field of digestive system diseases
Liao, G., Xie, Y., Peng, H., Li, T., Zou, X., Yue, F., Guo, J., & Rong, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05614-9 · Cited by 30
Braidy, N., Grant, R., & Sachdev, P. S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000394 · Cited by 27
Jane, E. P., Premkumar, D. R., Thambireddy, S., Golbourn, B. J., Agnihotri, S., Bertrand, K. C., Mack, S. C., Myers, M. I., Chattopadhyay, A., Taylor, D. L., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0669 · Cited by 27
“NADþ is a cofactor for multiple oxidoreductases (43) and a substrate for PARPs thereby having the ability to control druginduced oxidative and replicative stress, respectively (44, 45).”
BackgroundNAD+ Metabolism and Diseases with Motor Dysfunction
Lundt, S., & Ding, S. (2021) · Genes · doi:10.3390/genes12111776 · Cited by 28
“After NaMN is formed, it can enter the Preiss–Handler pathway to form NAD+ [7].”
BackgroundInfluentialGoldmann, O., & Medina, E. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04875-9 · Cited by 27
NAD+ Is a Food Component That Promotes Exit from Dauer Diapause in Caenorhabditis elegans
Mylenko, M., Boland, S., Penkov, S., Sampaio, J. L., Lombardot, B., Vorkel, D., Verbavatz, J., & Kurzchalia, T. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167208 · Cited by 29
Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death
Lu, Y., Bose, S., Ngo, A. H., & Do, L. H. (2017) · ChemMedChem · doi:10.1002/cmdc.201600638 · Cited by 27
Vitamin B3 forms as precursors to NAD+: Are they safe?
Poljšak, B., & Milisav, I. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.07.020 · Cited by 30
NAD-biosynthetic pathways regulate innate immunity
Billingham, L. K., & Chandel, N. S. (2019) · Nature Immunology · doi:10.1038/s41590-019-0353-x · Cited by 28
Lai, X., Huang, S., Lin, S., Pu, L., Wang, Y., Lin, Y., Huang, W., & Wang, Z. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02688-w · Cited by 26
“co‐cultured with MSCs Abundant literature demonstrated that Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells and NAD+ levels decline during aging and senescence [19].”
BackgroundCimaglia, G., Tribble, J. R., Votruba, M., Williams, P. A., & Morgan, J. E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01850-8 · Cited by 26
“The capacity to maintain NAD pools has emerged as a key factor in a range of age-related neurodegenerative conditions including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, glaucoma, and amyotrophic lateral sclerosis [1–6].”
BackgroundMitochondrial quality control: the real dawn of intervertebral disc degeneration?
Qiu, B., Xie, X., & Xi, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05943-9 · Cited by 31
“Dependence on NDA + as a coenzyme also makes Sirtuins a key sensor of cellular metabolism and REDOX status [173, 174].”
Paro, R., Grossniklaus, U., Santoro, R., & Wutz, A. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-68670-3 · Cited by 31
Ashimori, A., Nakahata, Y., Sato, T., Fukamizu, Y., Matsui, T., Yoshitane, H., Fukada, Y., Shinohara, K., & Bessho, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.647589 · Cited by 27
“…in Neuroscience | www.frontiersin.org 1 May 2021 | Volume 15 | Article 647589 such as sirtuins (SIRTs) and poly(ADP-ribose) polymerases (PARPs) to regulate a wide array of cellular processes such as survival/cell death, circadian clock, and aging (Imai and Guarente, 2014; Verdin, 2015).”
BackgroundNAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
Abdellatif, M., Bugger, H., Kroemer, G., & Sedej, S. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.111 · Cited by 35
The CD73 immune checkpoint promotes tumor cell metabolic fitness
Allard, D., Cousineau, I., Ma, E. H., Allard, B., Barèche, Y., Fleury, H., & Stagg, J. (2023) · eLife · doi:10.7554/elife.84508 · Cited by 28
“Intracellular NAD levels are maintained either by de novo synthesis from Ltryptophan (Trp), or by more effective salvage pathways that recycle NAD from nicotinamide (NAM), nicotinamide mononucleotide (NMN), or nicotinamide riboside (NR) (Verdin, 2015).”
BackgroundXu, C., Ma, W., Wang, H., Shao, L., Li, W., Yu, P., & Mao, L. (2023) · Nano Research · doi:10.1007/s12274-023-5931-4 · Cited by 27
Bai, J., Yu, B.-B., Li, C., Cheng, H., Guan, Y., Ren, Z., Zhang, T., Song, X., Jia, Z., Su, T., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302128 · Cited by 28
Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review
Lachlan, P., Shoushtarizadeh, A., Jelinek, G. A., Brown, C. R., Lim, C. K., Livera, A. M. D., Jacobs, K. R., & Weiland, T. J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.574133 · Cited by 27
“Given the recent interest in NAD and its link with aging and metabolic disease, especially as described by Chini et al., it may be worthwhile to further explore the role of NAD both in the treatment and pathogenesis of MS (Verdin, 2015).”
BackgroundMitochondrial and Autophagic Regulation of Adult Neurogenesis in the Healthy and Diseased Brain
Büeler, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073342 · Cited by 28
“Mitochondria-localized sirtuins regulate mitochondrial respiration and signaling, as well as mitochondrial biogenesis through PGC1α [182,184,185].”
BackgroundImplications of endoplasmic reticulum stress and autophagy in aging and cardiovascular diseases
Ma, C., Liu, Y., & Fu, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1413853 · Cited by 28
“Sirtuins are a family of nicotine adenine dinucleotide (NAD+)- dependent histone deacetylases, which are referred to as “ the fountain of youth ” due to their critical function in longevity and aging anomalies (Kan fi et al., 2012; Verdin, 2015).”
BackgroundKotova, P. D., Bystrova, M. F., Rogachevskaja, O. A., Khokhlov, A. A., Sysoeva, V., Va, T., & Kolesnikov, S. S. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.11.001 · Cited by 25
Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment
Zhang, T., Zhang, J., Lv, C., Li, H., & Song, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059434 · Cited by 29
“…the control of IPF by MSCs. Studies on animal models have found that supplementation with NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NM) can promote autophagy and have significant anti-aging effects (Verdin, 2015; Lautrup et al., 2019; Ruaro et al., 2021).”
BackgroundThe Double-Edged Role of Extracellular Vesicles in the Hallmarks of Aging
Romero-García, N., Huete-Acevedo, J., Mas‐Bargues, C., Sanz‐Ros, J., Dromant, M., & Borrás, C. (2023) · Biomolecules · doi:10.3390/biom13010165 · Cited by 27
Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo
Stock, A. J., Ayyar, S., Kashyap, A., Wang, Y., Yanai, H., Starost, M. F., Tanaka-Yano, M., Bodogai, M., Sun, C., Wang, Y., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00752-2 · Cited by 22
“A decline in NAD levels has emerged as an important hallmark of aging, including stem cell exhaustion, while supplementation with NAD pre-cursors improved NAD levels and health span in aged and DNA repair-deficient animal models with premature aging phenotypes [30, 31, 33–37].”
BackgroundCarreira, Á. S. A., Ravera, S., Zucal, C., Thongon, N., Caffa, I., Astigiano, C., Bertola, N., Buongiorno, A., Roccuzzo, M., Bisio, A., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100903 · Cited by 27
Long, A., Klimova, N., & Kristián, T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.009 · Cited by 28
“…how significantly the pathophysiology of mitochondria contribute to mechanisms of cell death (Brunyanszki et al., 2016) and what role does mitochondrial dynamics and disruption in normal NADþ anabolism/catabolism play in the process (Fouquerel and Sobol, 2014; Owens et al., 2015; Verdin, 2015).”
Croft, T., Raj, C. J. T., Salemi, M., Phinney, B. S., & Lin, S.-J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807214 · Cited by 27
“Aberrant NAD metabolism is associated with a number of diseases including diabetes, cancer, and neuron degeneration (2,3,5-8).”
BackgroundLiu, Z., Cheng, Y., Luan, Y., Zhong, W., Lai, H., Wang, H., Yu, H., Yang, Y., Feng, N., Yuan, F., et al. (2018) · FEBS Letters · doi:10.1002/1873-3468.13240 · Cited by 28
Zhou, C., Zhang, Z.-Q., Zhang, L., Liu, Y., & Liu, P. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736458 · Cited by 25
The Role of NAD+ in Regenerative Medicine
Conlon, N. J. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009673 · Cited by 30
“11 Chronically low NAD+ has been observed in accelerated aging disorders 12 and age-related disease states, 13–15 and has been linked to multiple hallmarks of aging.”
Gonzalez, L., & Bezzi, P. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70092 · Cited by 25
“Notably, similar network abnormalities are observed in first-degree relatives of OCD patients, supporting a heritable neural endophenotype hypothesis (Gillan and Robbins 2014; Ahmari et al. 2013; Burguière et al. 2013, 2015).”
Mitochondria‐Nuclear Crosstalk: Orchestrating mtDNA Maintenance
Darfarin, G., & Pluth, J. M. (2025) · Environmental and Molecular Mutagenesis · doi:10.1002/em.70013 · Cited by 26
“Conversely, interventions that restore NAD+ levels, such as nicotinamide riboside supplementation, have been shown to enhance mtDNA stability and promote mitochondrial quality control (Verdin 2015).”
Huang, T., Takashima, Y., Kumar, J., Morales, J., Le, K., Hu, Z., Rubino, S., Trousdale, R. T., Berry, G. J., Goronzy, J. J., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.019 · Cited by 25
Modulation of NAD+ biosynthesis activates SIRT1 and resists cisplatin-induced ototoxicity
Zhan, T., Xiong, H., Pang, J., Zhang, W., Ye, Y., Liang, Z., Huang, X., He, F., Jian, B., He, W., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.013 · Cited by 25
Zhao, S., Hong, Y. S., Liang, Y.-Y., Li, X., Shen, J., Sun, C.-C., Chu, L., Hu, J., Wang, H., Xu, D., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102414 · Cited by 25
Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibility
Ma, Y., Yi, M., Wang, W., Liu, X., Wang, Q., Liu, C., Chen, Y., & Deng, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05383-7 · Cited by 29
“As an essential cofactor of redox enzymes and a substrate for deacetylases, NAD declines during chronological aging resulting in mitochondrial dysfunction, oxidative stress, DNA damage, and cognitive impairment [1, 2].”
BackgroundMeta-analysis of NAD(P)(H) quantification results exhibits variability across mammalian tissues
Azouaoui, D., Choinière, M. R., Khan, M., Sayfi, S., Jaffer, S., Yousef, S., Patten, D. A., Green, A. E., & Menzies, K. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-29607-8 · Cited by 25
Piezoelectric Catalysis Induces Tumor Cell Senescence to Boost Chemo‐Immunotherapy
Hao, Z., Guo, S., Tu, W., Wang, Q., Wang, J., Zhang, X., He, Y., & Gao, D. (2024) · Small · doi:10.1002/smll.202309487 · Cited by 24
The MacroH2A1.1 – PARP1 Axis at the Intersection Between Stress Response and Metabolism
Hurtado-Bagès, S., Guberović, I., & Buschbeck, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00417 · Cited by 25
“Frontiers in Genetics | www.frontiersin.org 6 October 2018 | Volume 9 | Article 417 reactions than its de novo synthesis from dietary sources (reviewed in Verdin, 2015).”
BackgroundRaj, C. J. T., Croft, T., Venkatakrishnan, P., Groth, B., Dhugga, G., Cater, T., & Lin, S.-J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006987 · Cited by 24
Corneal Denervation Causes Epithelial Apoptosis Through Inhibiting NAD + Biosynthesis
Li, Y., Ma, X., Li, J., Yang, L., Zhao, X., Qi, X., Zhang, X., Zhou, Q., & Shi, W. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-26909 · Cited by 24
Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy
Singh, N., Pay, S. L., Bhandare, S. B., Arimpur, U., & Motea, E. A. (2020) · Cancers · doi:10.3390/cancers12040972 · Cited by 25
Cros, C., Cannelle, H., Laganier, L., Grozio, A., & Canault, M. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112060 · Cited by 23
Sarkar, A., Dutta, S., Sur, M., Chakraborty, S., Dey, P., & Mukherjee, P. (2022) · FEBS Journal · doi:10.1111/febs.16652 · Cited by 26
NAD+ metabolism and therapeutic strategies in cardiovascular diseases
Shi, C., Wen, Z., Yang, Y., Shi, L., & Liu, D. (2024) · Atherosclerosis Plus · doi:10.1016/j.athplu.2024.06.001 · Cited by 26
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
Kolotyeva, N. A., Groshkov, A. A., Rozanova, N. A., Berdnikov, A. K., Novikova, S. V., Komleva, Y. K., Salmina, A. B., Illarioshkin, S. N., & Пирадов, М. А. (2024) · Biomolecules · doi:10.3390/biom14121556 · Cited by 24
“…enzymes, including PARP, CD38, and CD157 [289–292]; (2) stimulation of NAD+ biosynthesis through the action of enzymes that generate NAD+ [286,293,294]; (3) use of NAD+ precursors, such as nicotinamide riboside, nicotinamide mononucleotide, nicotinic acid, nicotinamide, and tryptophan…”
Zu, Y., Wu, C., Li, F., Yao, H., Xia, Y., Zhang, R., Li, L., Chen, S., Shi, Q., Xi, S., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.05.022 · Cited by 28
Metabolic Modulation of Macrophage Function Post Myocardial Infarction
Zhao, M., Wang, D. D.-H., Liu, X., & Tian, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00674 · Cited by 25
“Decreased OXPHOS lowers the NAD+/NADH ratio and reduces the availability of NAD+ for other NAD+-dependent proteins, such as poly ADP-ribose polymerase (PARP), cyclic ADP-ribose synthase, and sirtuins (Verdin, 2015; Katsyuba and Auwerx, 2017; Figure 2).”
BackgroundEvolution of natural lifespan variation and molecular strategies of extended lifespan in yeast
Kaya, A., Phua, C. Z. J., Lee, M. B., Wang, L., Tyshkovskiy, A., Ma, S., Barré, B. P., Liu, W., Harrison, B. R., Zhao, X., et al. (2021) · eLife · doi:10.7554/elife.64860 · Cited by 24
Impact of Environmental and Epigenetic Changes on Mesenchymal Stem Cells during Aging
Smith, N., Shirazi, S., Cakouros, D., & Gronthos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076499 · Cited by 26
NAD+ salvage governs the immunosuppressive capacity of mesenchymal stem cells
Fang, J., Hou, P., Liu, S., Zuo, M., Liu, Z., Chen, W., Han, Y., Li, Y., Wang, T., Feng, C., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01073-2 · Cited by 26
Metabolomics and mitochondrial dysfunction in cardiometabolic disease
Shastry, A., & Dunham‐Snary, K. J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122137 · Cited by 24
Sugisawa, R., Shanahan, K. A., Davis, G. M., Davey, G. P., & Bowie, A. (2024) · iScience · doi:10.1016/j.isci.2024.109940 · Cited by 25
“Decline in whole organism or tissue NAD + is a known symptom of aging, 47 as is increased chronic low-grade inflammation (so called ‘in-flammaging’).”
Intercellular communication is crucial in the regulation of healthy aging via exosomes
Sun, H., Xia, T., Ma, S., Lv, T., & Li, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107591 · Cited by 27
Biology, Chemistry, and Pharmacology of Sirtuins
Bedalov, A., Chowdhury, S., & Simon, J. A. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.03.011 · Cited by 23
Extracellular Vesicles: Recent Developments in Aging and Reproductive Diseases
Liu, Y., Shen, Q., Zhang, L., & Xiang, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.577084 · Cited by 28
“…skin, and neurosensory retina is decreased with age (Braidy et al., 2011; Gomes et al., 2013; Mouchiroud et al., 2013; Khan et al., 2014; Canto et al., 2015; Verdin, 2015; Lin et al., 2018; Rajman et al., 2018; Yoshino et al., 2018). eNAMPT is an essential NAD+ biosynthetic enzyme in mammals.”
BackgroundThe multifaceted roles of DNA repair and replication proteins in aging and obesity
D’Amico, A. M., & Vásquez, K. M. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103049 · Cited by 27
“Dysregulation of NAD+ levels and altered mitochondrial function are prominent in metabolic and premature aging disorders[184].”
BackgroundBock, K. W. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03134-9 · Cited by 26
“NAD+-consumption is carried out by multiple enzymes such as CD38 (Verdin 2015; Yang * Karl Walter Bock bock@uni-tuebingen.de 1 Institute of Experimental and Clinical Pharmacology and Toxicology, Wilhelmstrasse 56, 72074 Tübingen, Germany 1 3 and Sauve 2016), 17 PARPs including the AHR target gene…”
BackgroundInfluentialSehgal, M., Jakhete, S. M., Manekar, A. G., & Sasikumar, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09773 · Cited by 24
Ramachandran, D., Clara, R., Fedele, S., Hu, J., Lackzo, E., Huang, J.-Y., Verdin, E. M., Langhans, W., & Mansouri, A. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.009 · Cited by 25
“NADþ is the cosubstrate for several enzymes, one of which is SIRT3 [17].”
BackgroundSelf-citationNAD+ augmentation with nicotinamide riboside improves lymphoid potential of Atm−/− and old mice HSCs
Zong, L., Tanaka-Yano, M., Park, B., Yanai, H., Turhan, F. T., Croteau, D. L., Tian, J., Fang, E. F., Bohr, V. A., & Beerman, I. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00078-3 · Cited by 22
He, Y., He, T., Li, H., Chen, W., Zhong, B., Wu, Y., Chen, R., Hu, Y., Ma, H., Wu, B., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116428 · Cited by 29
Effects of Aging on Glucose and Lipid Metabolism in Mice
Lien, E. C., Vu, N., Westermark, A. M., Danai, L. V., Lau, A. N., Gültekin, Y., Kukurugya, M. A., Bennett, B. D., & Heiden, M. G. V. (2024) · Aging Cell · doi:10.1111/acel.14462 · Cited by 24
“The proposed mechanisms downstream of NAD + depletion that contribute to aging are largely focused around the role of NAD + as a cosubstrate for enzymes such as sirtuins and poly(ADP-ribose) polymerases (Verdin 2015).”
Bai, X., Li, Y., Wang, P., Xu, Z., Wei, J., He, T., & Han, J. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf017 · Cited by 24
“Emerging evidence suggests that dysregulation of NAD + metabolism is increasingly recognized as a critical factor in the pathogenesis of various diabetes complications in individuals with diabetes [52].”
Liang, K., Zhao, L., Zhang, S., Zheng, L., Zhang, Z., Wang, S., Chen, J., Xu, W., Wang, W., Yang, H., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-02017-9 · Cited by 29
Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
Velázquez-Torres, G., Fuentes‐Mattei, E., Choi, H. H., Yeung, S. J., Meng, X., & Lee, M. (2020) · Gastroenterology report · doi:10.1093/gastro/goaa018 · Cited by 23
De novo NAD+ synthesis contributes to CD8+ T cell metabolic fitness and antitumor function
Wan, J., Cheng, C., Hu, J., Huang, H., Han, Q., Jie, Z., Zou, Q., Shi, J., & Yu, X. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113518 · Cited by 26
Yusri, K., Kumar, S., Fong, S., Gruber, J., & Sorrentino, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126793 · Cited by 25
“NAD + can be quantified from muscle biopsies, red blood cells, and saliva through biochemical assays (e.g., enzymatic and calorimetric assay), which are highly sensitive and affordable [388,402–404].”
BackgroundMolecular mechanisms in the initiation phase of Wallerian degeneration
Chang, B., Quan, Q., Lu, S., Wang, Y., & Peng, J. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13250 · Cited by 23
“NAD+ and nicotinamide adenine dinucleotide phosphate (NADP+) serve as co-enzymes in the redox reactions for hydrogen transfer and play vital roles in the production of energy for various physiological functions in axons (Araki et al., 2004; Wang et al., 2005; Bogan & Brenner, 2008; Verdin, 2015).”
BackgroundInfluentialStress-Induced Premature Senescence of Endothelial and Endothelial Progenitor Cells
Goligorsky, M. S., & Hirschi, K. K. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.04.007 · Cited by 24
“NAD+ bioavailability is reduced in disease states and aging (Verdin, 2015).”
BackgroundTranscriptome Analyses of Heart and Liver Reveal Novel Pathways for Regulating Songbird Migration
Horton, W. J., Jensen, M., Sebastian, A., Praul, C. A., Albert, I. U., & Bartell, P. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41252-8 · Cited by 35
Aging Biomarkers and Novel Targets for Anti-Aging Interventions
Xu, K., Guo, Y., Li, Z., & Wang, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_3 · Cited by 26
Nicotinamide mononucleotide ameliorates senescence in alveolar epithelial cells
Fang, T., Yang, H. J., Liu, L., Xiao, H., & Wei, X. (2021) · MedComm · doi:10.1002/mco2.62 · Cited by 22
Sirtfoods: New Concept Foods, Functions, and Mechanisms
Akan, O. D., Qin, D., Guo, T., Lin, Q., & Luo, F. (2022) · Foods · doi:10.3390/foods11192955 · Cited by 23
Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation
Röderer, P., Klatt, L., John, F., Theis, V., Winklhofer, K. F., Theiß, C., & Matschke, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0999-7 · Cited by 28
“Lower NAD+ levels are described to lead to the inhibition of SIRT1 and SIRT3 (Verdin 2015, Jasper 2013).”
BackgroundLundt, S., Zhang, N., Wang, X., Polo‐Parada, L., & Ding, S. (2020) · Scientific Reports · doi:10.1038/s41598-019-57085-4 · Cited by 20
Mitophagy: An Emergence of New Player in Alzheimer’s Disease
Sharma, B., Pal, D., Sharma, U., & Kumar, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.921908 · Cited by 23
“Furthermore, enzymes other than SIRTs that use NAD as a co-factor are found to be alerted in neurodegenerative diseases such as poly (ADP-ribose) polymerase 1 (PARP1), and cyclic ADP ribose hydrolase (CD38) (Verdin, 2015).”
BackgroundInfluentialFrom Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
Zhu, Y., Xu, P., Huang, X., Wen, S., Liu, L., Zhang, S., Zhao, R., Hu, X., & Wang, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.920113 · Cited by 23
“Therefore, the role of SIRTs in neurological diseases has been well concerned.”
BackgroundInfluentialNicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
Schaefer, P. M., Huang, J. Y., Butic, A., Perry, C. E., Yardeni, T., Tan, W., Morrow, R. M., Baur, J. A., & Wallace, D. C. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101560 · Cited by 25
“It has been suggested that boosting NADþ is more effective in aged individuals than younger ones [35,38] due to the decreasing levels of NADþ and NAD salvage pathway expression with age (reviewed in [13]).”
BackgroundResearch Progress on the Role of Sirtuin 1 in Cerebral Ischemia
Fangma, Y., Wan, H., Shao, C., Jin, L., & He, Y. G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01288-3 · Cited by 22
Metabolome Profiling in Aging Studies
Balashova, E. E., Maslov, D. L., Trifonova, O. P., Lokhov, P. G., & Archakov, A. I. (2022) · Biology · doi:10.3390/biology11111570 · Cited by 25
“Another sirtuin activator is NAD+, a classical coenzyme mediating many redox reactions, whose participation in antiaging therapy has been actively discussed [36,37].”
BackgroundInduction of Metabolic Reprogramming in Kidney by Singlet Diradical Nanoparticles
Ye, L., Jiang, S., Hu, J., Wang, M., Weng, T., Wu, F. Y., Cai, L., Sun, Z., & Ma, L. (2023) · Advanced Materials · doi:10.1002/adma.202301338 · Cited by 24
Metadata
- Authors
- Verdin, E.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Verdin, Eric
- ORCID
- Verdin, Eric
- Venue
- Science
- Published
- 2015-12-04
- Volume
- 350
- Issue
- 6265
- Pages
- 1208-1213
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2284984697
- Cited by
- 1,319
- References
- 116
- Citations by year
- 2026: 177 · 2025: 149 · 2024: 137 · 2023: 120 · 2022: 129 · 2021: 171 · 2020: 123 · 2019: 112 · 2018: 89 · 2017: 70 · 2016: 40 · 2015: 1
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK085610)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- NAD+, aging, metabolism, neurodegeneration, sirtuins, poly(ADP-ribose) polymerase, NAD+ precursors, NAD+ supplementation, healthspan, lifespan, redox reactions, coenzymes
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, DNA Damage, Fatty Liver, Humans, Mitochondria, NAD, Obesity, Oxidation-Reduction, Poly(ADP-ribose) Polymerases, Neurodegenerative Diseases, Sirtuins, Biosynthetic Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.